Calibrating kidney function for cancer patients

December 10, 2020

Cold Spring Harbor Laboratory (CSHL) scientists have developed a new model for assessing kidney function in cancer patients as part of an international collaboration that involved contributions from the United Kingdom and Sweden. The model gives clinicians a new tool to aid dose determinations for chemotherapy to treat a patient's disease while limiting the drugs' harmful effects.

Chemotherapy drugs are usually injected into the bloodstream and removed from the body as blood filters through the kidneys. Sometimes the drugs harm the kidneys. Understanding how efficiently a patient can filter blood is essential for predicting how the body will process a drug and monitoring treatment effects. To be sure a treatment reaches tumor cells at the right dose, patients whose kidneys remove compounds from their blood efficiently will need more drug than someone whose kidney function is impaired. Calculating an appropriate dose is a crucial balancing act. CSHL Assistant Professor Tobias Janowitz, the senior author of the study, says:

"This is the constant balance that we are trying to get right in cancer therapy across the board. We have to be careful to make sure that we don't put the patient at risk. And we have to make sure that we dose the drugs in a way that we get this balance right between how effective is the drug and how many side effects does the drug cause."

Clinicians assess kidney function before every round of cancer treatment. Measuring the kidneys' filtration rate directly is costly and requires specialized facilities, so instead, it is frequently estimated by measuring how much creatinine--a chemical waste product--is in the blood. The relationship between creatinine levels and filtration rate depends on several factors, including age, gender, and body mass index. Mathematical models are used to integrate these data.

Previous models were developed using data from patients with kidney disease, whose failing kidney function must be closely monitored. But it hasn't been clear how those models represent what's happening in patients with cancer, Janowitz says. "Cancer patients may have a unique physiology, and most of them don't have impaired kidney function. So, it is conceivable that the models that are available don't serve cancer patients so well."

Janowitz and his colleagues, including CSHL fellow Hannah Meyer, developed their model using data from patients at three cancer centers. The new model, described in the journal Clinical Cancer Research, is compatible with two widely used methods for measuring creatinine and provides enough precision to guide clinical decisions. Follow-up studies will be needed to determine whether using the new model improves treatment outcomes for cancer patients.

Cold Spring Harbor Laboratory

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to